Narcolepsy Type 1 with Cataplexy Studies

Avadel (once nightly sodium oxybate)

  • 2-year study
  • Must already be on a stable dose of twice-nightly sodium oxybate (Xyrem or Xywav) for at least 4 weeks
  • 16 years of age or older
  • Must have primary diagnosis of Narcolepsy

Axsome (reboxetine)

  • 8-10 weeks
  • Placebo controlled study
  • 15-75 years of age
  • Must have primary diagnosis of Narcolepsy Type 1 with Cataplexy
  • History of >14 cataplexy attacks in 2-week period
  • Optional open extension period with guaranteed study drug